A detailed history of Trustmark National Bank Trust Department transactions in Merck & Co., Inc. stock. As of the latest transaction made, Trustmark National Bank Trust Department holds 18,317 shares of MRK stock, worth $1.8 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
18,317
Previous 27,204 32.67%
Holding current value
$1.8 Million
Previous $3.37 Million 38.22%
% of portfolio
0.16%
Previous 0.27%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$111.15 - $128.97 $987,790 - $1.15 Million
-8,887 Reduced 32.67%
18,317 $2.08 Million
Q2 2024

Aug 14, 2024

BUY
$123.8 - $132.96 $73,165 - $78,579
591 Added 2.22%
27,204 $3.37 Million
Q1 2024

May 10, 2024

BUY
$113.24 - $131.95 $249,128 - $290,290
2,200 Added 9.01%
26,613 $3.51 Million
Q4 2023

Feb 14, 2024

SELL
$100.18 - $109.02 $461,429 - $502,146
-4,606 Reduced 15.87%
24,413 $2.66 Million
Q3 2023

Nov 13, 2023

SELL
$102.95 - $114.33 $655,482 - $727,939
-6,367 Reduced 17.99%
29,019 $2.99 Million
Q2 2023

Aug 10, 2023

SELL
$108.61 - $118.38 $1.01 Million - $1.1 Million
-9,286 Reduced 20.79%
35,386 $4.08 Million
Q1 2023

May 10, 2023

BUY
$102.94 - $114.86 $2,367 - $2,641
23 Added 0.05%
44,672 $4.75 Million
Q4 2022

Feb 14, 2023

SELL
$87.44 - $112.11 $17,488 - $22,422
-200 Reduced 0.45%
44,649 $4.95 Million
Q3 2022

Nov 09, 2022

BUY
$84.53 - $94.96 $53,592 - $60,204
634 Added 1.43%
44,849 $3.86 Million
Q2 2022

Aug 11, 2022

BUY
$83.49 - $94.64 $492,006 - $557,713
5,893 Added 15.38%
44,215 $4.03 Million
Q1 2022

May 12, 2022

BUY
$73.51 - $82.4 $51,971 - $58,256
707 Added 1.88%
38,322 $3.14 Million
Q4 2021

Feb 11, 2022

SELL
$72.28 - $90.54 $2.79 Million - $3.5 Million
-38,609 Reduced 50.65%
37,615 $2.88 Million
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $2.3 Million - $2.53 Million
32,059 Added 72.59%
76,224 $5.73 Million
Q2 2021

Aug 11, 2021

SELL
$70.31 - $77.77 $189,344 - $209,434
-2,693 Reduced 5.75%
44,165 $3.44 Million
Q1 2021

May 14, 2021

BUY
$68.86 - $81.11 $553,152 - $651,556
8,033 Added 20.69%
46,858 $3.61 Million
Q4 2020

Feb 16, 2021

BUY
$71.77 - $79.65 $43,564 - $48,347
607 Added 1.59%
38,825 $3.18 Million
Q3 2020

Nov 13, 2020

SELL
$73.18 - $82.95 $206,733 - $234,333
-2,825 Reduced 6.88%
38,218 $3.17 Million
Q2 2020

Aug 12, 2020

BUY
$70.42 - $80.13 $175,557 - $199,764
2,493 Added 6.47%
41,043 $3.17 Million
Q1 2020

May 14, 2020

SELL
$63.36 - $87.82 $177,217 - $245,632
-2,797 Reduced 6.76%
38,550 $2.97 Million
Q4 2019

Feb 14, 2020

BUY
$77.58 - $87.54 $51,901 - $58,564
669 Added 1.64%
41,347 $3.76 Million
Q3 2019

Nov 14, 2019

BUY
$76.08 - $82.93 $268,942 - $293,157
3,535 Added 9.52%
40,678 $3.42 Million
Q2 2019

Aug 13, 2019

SELL
$69.84 - $81.59 $438,455 - $512,222
-6,278 Reduced 14.46%
37,143 $3.11 Million
Q1 2019

May 13, 2019

BUY
$69.58 - $79.36 $248,261 - $283,156
3,568 Added 8.95%
43,421 $3.61 Million
Q4 2018

Feb 14, 2019

SELL
$65.24 - $75.71 $204,527 - $237,350
-3,135 Reduced 7.29%
39,853 $3.05 Million
Q3 2018

Feb 22, 2019

SELL
$57.69 - $67.84 $374,119 - $439,942
-6,485 Reduced 13.11%
42,988 $3.05 Million
Q3 2018

Nov 14, 2018

BUY
$57.69 - $67.84 $393,157 - $462,329
6,815 Added 15.98%
49,473 $3.51 Million
Q2 2018

Aug 14, 2018

SELL
$50.83 - $59.72 $271,584 - $319,083
-5,343 Reduced 11.13%
42,658 $2.59 Million
Q1 2018

May 15, 2018

SELL
$50.96 - $59.23 $9,988 - $11,609
-196 Reduced 0.41%
48,001 $2.61 Million
Q4 2017

Feb 14, 2018

SELL
$51.62 - $61.64 $83,830 - $100,103
-1,624 Reduced 3.26%
48,197 $2.71 Million
Q3 2017

Nov 09, 2017

BUY
$58.67 - $63.13 $2.92 Million - $3.15 Million
49,821
49,821 $3.19 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Trustmark National Bank Trust Department Portfolio

Follow Trustmark National Bank Trust Department and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trustmark National Bank Trust Department, based on Form 13F filings with the SEC.

News

Stay updated on Trustmark National Bank Trust Department with notifications on news.